NICE Approves Gene Therapy for Sickle Cell: A B...

By João L. Carapinha

February 4, 2025

Are we on the brink of a cure for sickle cell disease? NICE recently announced the approval of a one-off gene therapy sickle cell for severe sickle cell disease. Epidemiology of Sickle Cell Disease Sickle cell disease affects a signific...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.